Acinetobacter Infections Treatment Market

Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or ?species? of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
Acinetobacter Infections Treatment Market aims to provide a comprehensive presentation of the global market for Acinetobacter Infections Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Acinetobacter Infections Treatment. Acinetobacter Infections Treatment Market contains market size and forecasts of Acinetobacter Infections Treatment in global, including the following market information:
Global Acinetobacter Infections Treatment Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Acinetobacter Infections Treatment market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
In the American market, Major manufacturers include Entasis Therapeutics, Roche, Adenium Biotech, Vaxdyn, Hsiri Therapeutics, Aridis Pharmaceuticals, and Legochem Biosciences, Atterx Biotherapeutics, Achaogen, Peptilogics, Sealife Pharma, Shionogi, Techulon and Tetraphase Pharmaceuticals, among others. Entasis Therapeutics, Roche and Adenium Biotech are the top 3 players of Acinetobacter Infections Treatment, with about 66% market shares.
We surveyed the Acinetobacter Infections Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Acinetobacter Infections Treatment Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Acinetobacter Infections Treatment Market Segment Percentages, by Type, 2022 (%)
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
Global Acinetobacter Infections Treatment Market, by Pipeline, 2018-2023, 2024-2029 ($ millions)
Global Acinetobacter Infections Treatment Market Segment Percentages, by Pipeline, 2022 (%)
ETX2514
Nacubactam RG6080
Arenicin
VXD-001
Small Molecule Antibiotic
AR-401 mAB
LCB01-0371 (PO)
GN-4474
Antibacterial Antibody
Others
Global Acinetobacter Infections Treatment Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Acinetobacter Infections Treatment Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Acinetobacter Infections Treatment revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Acinetobacter Infections Treatment revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Acinetobacter Infections Treatment, market overview.
Chapter 2: Global Acinetobacter Infections Treatment market size in revenue.
Chapter 3: Detailed analysis of Acinetobacter Infections Treatment company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by pipeline, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Acinetobacter Infections Treatment in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.